Strategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
4
Meta Platforms
META
5
Salesforce
CRM
US Stock MarketDetailed Quotes
ANIP ANI Pharmaceuticals
- 70.760
- +0.010+0.01%
Close Apr 29 16:00 ET
- 70.000
- -0.760-1.07%
Post 16:50 ET
1.54BMarket Cap-68.04P/E (TTM)
72.570High69.987Low385.84KVolume70.830Open70.750Pre Close27.55MTurnover2.30%Turnover RatioLossP/E (Static)21.76MShares72.57052wk High3.81P/B1.19BFloat Cap52.50052wk Low--Dividend TTM16.77MShs Float392.040Historical High--Div YieldTTM3.65%Amplitude4.800Historical Low71.403Avg Price1Lot Size
ANI Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -46.19%64.02M | -64.55%15.86M | -61.22%12.47M | -15.57%17.41M | -14.73%18.27M | 481.24%118.96M | 1,116.82%44.74M | 787.91%32.17M | 279.61%20.63M | 213.10%21.42M |
| Net income from continuing operations | -198.63%-18.52M | -989.70%-10.28M | -343.12%-24.17M | -136.62%-2.29M | 1,165.25%18.21M | 139.21%18.78M | 127.22%1.16M | 215.58%9.94M | 141.85%6.25M | 107.15%1.44M |
| Operating gains losses | --2.12M | --0 | --7.47M | --0 | ---5.35M | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 13.28%67.73M | 48.74%22.6M | 3.56%15.75M | 0.05%14.7M | -0.10%14.69M | 0.23%59.79M | -2.43%15.19M | -0.93%15.21M | 3.64%14.69M | 0.98%14.7M |
| Deferred tax | -86.65%-21.91M | -110.04%-17.53M | -71.57%-5.59M | -108.68%-1.9M | 301.55%3.1M | 23.03%-11.74M | -413.60%-8.35M | -44.76%-3.26M | 76.75%-910K | 110.36%773K |
| Other non cash items | 128.93%15.15M | 177.19%9.2M | 722.98%4.55M | -60.04%832K | -71.00%565K | -27.84%6.62M | 13.55%3.32M | -115.82%-731K | 2,027.78%2.08M | 12.28%1.95M |
| Change In working capital | -144.99%-11.19M | -117.21%-4.78M | 49.62%8.33M | 33.06%-4.51M | -476.38%-10.23M | 148.46%24.86M | 233.88%27.8M | 159.43%5.57M | 34.62%-6.73M | 83.69%-1.77M |
| -Change in receivables | -727.78%-21.09M | -252.20%-25.51M | 242.58%8.44M | 253.66%6.33M | -11.47%-10.34M | 109.10%3.36M | 167.04%16.76M | -159.32%-5.92M | 109.52%1.79M | -199.29%-9.28M |
| -Change in inventory | -264.44%-21.29M | 85.34%-675K | -180.42%-6.36M | -1,635.58%-11.61M | -255.26%-2.64M | 75.28%-5.84M | 51.33%-4.61M | 31.52%-2.27M | 92.88%-669K | 216.35%1.7M |
| -Change in prepaid assets | 123.62%2.13M | 79.79%-1.69M | 816.89%13.08M | -3,163.69%-10.61M | -10.58%1.35M | -1,029.70%-9.02M | -145.36%-8.38M | -273.06%-1.82M | -119.12%-325K | 1,204.38%1.51M |
| -Change in payables and accrued expense | -50.20%19.96M | -29.05%18.29M | -149.53%-6.9M | 422.05%10.34M | -149.58%-1.77M | 222.31%40.08M | 45.65%25.78M | 186.18%13.94M | -119.07%-3.21M | 160.26%3.57M |
| -Change in other working capital | 344.55%9.1M | 372.91%4.81M | -95.30%77K | 124.22%1.05M | 345.16%3.17M | -55.15%-3.72M | -203.10%-1.76M | 279.23%1.64M | -558.63%-4.31M | 387.50%713K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -46.19%64.02M | -64.55%15.86M | -61.22%12.47M | -15.57%17.41M | -14.73%18.27M | 481.24%118.96M | 1,116.82%44.74M | 787.91%32.17M | 279.61%20.63M | 213.10%21.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2,086.37%-404.72M | -123.50%-10.68M | -8,652.95%-398.52M | 34.82%-4.45M | 479.64%8.93M | -17.62%-18.51M | -52.10%-4.78M | 53.61%-4.55M | -1,030.13%-6.83M | -8.03%-2.35M |
| Net PPE purchase and sale | 69.31%-2.72M | -5.05%-2.39M | -176.71%-4.81M | -77.89%-4.45M | 480.29%8.93M | -9.13%-8.87M | 27.37%-2.28M | 29.54%-1.74M | -338.00%-2.5M | -20.52%-2.35M |
| Net intangibles purchase and sale | 92.56%-717K | 96.56%-86K | 77.58%-631K | --0 | --0 | -27.23%-9.64M | -62,400.00%-2.5M | 61.69%-2.81M | ---4.33M | 98.25%-4K |
| Net business purchase and sale | ---401.28M | ---8.2M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -2,086.37%-404.72M | -123.50%-10.68M | -8,652.95%-398.52M | 34.82%-4.45M | 479.64%8.93M | -17.62%-18.51M | -52.10%-4.78M | 53.61%-4.55M | -1,030.13%-6.83M | -8.03%-2.35M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 292.87%264.95M | 58.83%-4.91M | 7,650.47%291.03M | -101.81%-1.45M | -333.73%-19.73M | 1,415.63%67.44M | -2,246.06%-11.92M | 512.18%3.76M | 5,677.59%80.15M | -100.35%-4.55M |
| Net issuance payments of debt | 11,607.30%345.22M | -170.80%-2.03M | 46,600.00%348.75M | 0.00%-750K | 0.00%-750K | 0.00%-3M | 0.00%-750K | 0.00%-750K | 0.00%-750K | 0.00%-750K |
| Net common stock issuance | -114.50%-10.96M | -119.75%-10.96M | --0 | -89.70%8.66M | -144.04%-8.66M | 3,957.48%75.57M | -4,090.76%-4.99M | --0 | 17,512.84%84.1M | -217.44%-3.55M |
| Cash dividends paid | 0.00%-1.63M | 0.00%-406K | 0.00%-406K | 0.00%-407K | 0.00%-406K | 0.00%-1.63M | 0.25%-406K | 0.00%-406K | 0.00%-407K | -0.25%-406K |
| Proceeds from stock option exercised by employees | -27.88%6.49M | 83.51%12.34M | -89.57%512K | -220.20%-8.96M | 1,550.32%2.59M | 517.01%9M | 775.65%6.73M | 914.67%4.91M | -1,477.83%-2.8M | 5,133.33%157K |
| Net other financing activities | -493.42%-74.18M | ---3.85M | ---57.83M | --0 | ---12.5M | ---12.5M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 292.87%264.95M | 58.83%-4.91M | 7,650.47%291.03M | -101.81%-1.45M | -333.73%-19.73M | 1,415.63%67.44M | -2,246.06%-11.92M | 512.18%3.76M | 5,677.59%80.15M | -100.35%-4.55M |
| Net cash flow | ||||||||||
| Beginning cash position | 315.38%221.12M | -24.89%145.02M | 48.48%240.11M | 237.38%228.6M | 315.38%221.12M | -49.45%53.23M | 215.05%193.08M | 136.46%161.71M | -17.28%67.76M | -49.45%53.23M |
| Current changes in cash | -145.12%-75.76M | -99.03%272K | -402.88%-95.02M | -87.75%11.51M | -48.52%7.48M | 422.44%167.89M | 448.36%28.04M | 541.72%31.37M | 794.64%93.95M | 162.09%14.52M |
| Effect of exchange rate changes | ---470K | ---395K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| End cash Position | -34.47%144.89M | -34.47%144.89M | -24.89%145.02M | 48.48%240.11M | 237.38%228.6M | 315.38%221.12M | 315.38%221.12M | 215.05%193.08M | 136.46%161.71M | -17.28%67.76M |
| Free cash flow | -53.15%47.06M | -66.52%13.38M | -74.54%7.03M | -6.05%12.97M | -28.23%13.69M | 310.77%100.45M | 629.85%39.96M | 546.07%27.62M | 207.77%13.8M | 190.30%19.07M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025